{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:56:48Z","timestamp":1773899808720,"version":"3.50.1"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:00:00Z","timestamp":1323216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12020-011-9569-8","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T09:50:34Z","timestamp":1323165034000},"page":"200-219","source":"Crossref","is-referenced-by-count":47,"title":["Sex hormone replacement in Turner syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"Christian","family":"Trolle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Hjerrild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Cleemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian H.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus H.","family":"Gravholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"key":"9569_CR1","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2006-0558","volume":"91","author":"K Stochholm","year":"2006","unstructured":"K. Stochholm, S. Juul, K. Juel, R.W. Naeraa, C.H. Gravholt, Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J. Clin. Endocrinol. Metab. 91, 3897\u20133902 (2006). doi: 10.1210\/jc.2006-0558","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR2","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1210\/jc.2008-1049","volume":"93","author":"MJ Schoemaker","year":"2008","unstructured":"M.J. Schoemaker, A.J. Swerdlow, C.D. Higgins, A.F. Wright, P.A. Jacobs, Mortality in women with turner syndrome in Great Britain: a national cohort study. J. Clin. Endocrinol. Metab. 93, 4735\u20134742 (2008). doi: 10.1210\/jc.2008-1049","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0895-4356(97)00237-0","volume":"51","author":"CH Gravholt","year":"1998","unstructured":"C.H. Gravholt, S. Juul, R.W. Naeraa, J. Hansen, Morbidity in Turner syndrome. J. Clin. Epidemiol. 51, 147\u2013158 (1998)","journal-title":"J. Clin. Epidemiol."},{"key":"9569_CR4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(10)60355-8","volume":"376","author":"VM De","year":"2010","unstructured":"V.M. De, P. Devroey, B.C. Fauser, Primary ovarian insufficiency. Lancet 376, 911\u2013921 (2010). doi: 10.1016\/S0140-6736(10)60355-8","journal-title":"Lancet"},{"key":"9569_CR5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1210\/jcem-40-4-670","volume":"40","author":"FA Conte","year":"1975","unstructured":"F.A. Conte, M.M. Grumbach, S.L. Kaplan, A diphasic pattern of gonadotropin secretion in patients with the syndrome of gonadal dysgenesis. J. Clin. Endocrinol. Metab. 40, 670\u2013674 (1975)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.78.4.978","volume":"78","author":"C Heinrichs","year":"1994","unstructured":"C. Heinrichs, P. Bourdoux, C. Saussez, H.L. Vis, J.P. Bourguignon, Blood spot follicle-stimulating hormone during early postnatal life in normal girls and Turner\u2019s syndrome. J. Clin. Endocrinol. Metab. 78, 978\u2013981 (1994)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000179498","volume":"16","author":"D Apter","year":"1982","unstructured":"D. Apter, H.L. Lenko, J. Perheentupa, A. Soderholm, R. Vihko, Subnormal pubertal increases of serum androgens in Turner\u2019s syndrome. Horm. Res. 16, 164\u2013173 (1982)","journal-title":"Horm. Res."},{"key":"9569_CR8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2265.1999.00720.x","volume":"50","author":"CH Gravholt","year":"1999","unstructured":"C.H. Gravholt, B. Svenstrup, P. Bennett, C.J. Sandahl, Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status. Clin. Endocrinol. (Oxf.) 50, 791\u2013800 (1999)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/jc.82.1.57","volume":"82","author":"AM Boot","year":"1997","unstructured":"A.M. Boot, M.A. de Ridder, H.A. Pols, E.P. Krenning, S.M. de Muinck Keizer-Schrama, Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J. Clin. Endocrinol. Metab. 82, 57\u201362 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR10","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1359\/jbmr.1997.12.11.1851","volume":"12","author":"JC Prior","year":"1997","unstructured":"J.C. Prior, Y.M. Vigna, J.D. Wark, D.R. Eyre, B.C. Lentle, D.K. Li, P.R. Ebeling, L. Atley, Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate. J. Bone Miner. Res. 12, 1851\u20131863 (1997). doi: 10.1359\/jbmr.1997.12.11.1851","journal-title":"J. Bone Miner. Res."},{"key":"9569_CR11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/jc.75.4.1060","volume":"75","author":"G Theintz","year":"1992","unstructured":"G. Theintz, B. Buchs, R. Rizzoli, D. Slosman, H. Clavien, P.C. Sizonenko, J.P. Bonjour, Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16\u00a0years of age at the levels of lumbar spine and femoral neck in female subjects. J. Clin. Endocrinol. Metab. 75, 1060\u20131065 (1992)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2265.2003.01807.x","volume":"59","author":"CH Gravholt","year":"2003","unstructured":"C.H. Gravholt, P. Vestergaard, A.P. Hermann, L. Mosekilde, K. Brixen, J.S. Christiansen, Increased fracture rates in Turner\u2019s syndrome: a nationwide questionnaire survey. Clin. Endocrinol. (Oxf.) 59, 89\u201396 (2003)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2265.1999.00841.x","volume":"51","author":"K Landin-Wilhelmsen","year":"1999","unstructured":"K. Landin-Wilhelmsen, I. Bryman, M. Windh, L. Wilhelmsen, Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin. Endocrinol. (Oxf.) 51, 497\u2013502 (1999)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2007.04.031","volume":"151","author":"VK Bakalov","year":"2007","unstructured":"V.K. Bakalov, T. Shawker, I. Ceniceros, C.A. Bondy, Uterine development in Turner syndrome. J. Pediatr. 151, 528\u2013531 (2007). doi: 10.1016\/j.jpeds.2007.04.031","journal-title":"J. Pediatr."},{"key":"9569_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/humrep\/12.2.279","volume":"12","author":"G Khastgir","year":"1997","unstructured":"G. Khastgir, H. Abdalla, A. Thomas, L. Korea, L. Latarche, J. Studd, Oocyte donation in Turner\u2019s syndrome: an analysis of the factors affecting the outcome. Hum. Reprod. 12, 279\u2013285 (1997)","journal-title":"Hum. Reprod."},{"key":"9569_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ajmg.1320580115","volume":"58","author":"JL Ross","year":"1995","unstructured":"J.L. Ross, G. Stefanatos, D. Roeltgen, H. Kushner, G.B. Cutler Jr., Ullrich\u2013Turner syndrome: neurodevelopmental changes from childhood through adolescence. Am. J. Med. Genet. 58, 74\u201382 (1995). doi: 10.1002\/ajmg.1320580115","journal-title":"Am. J. Med. Genet."},{"key":"9569_CR17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00201540","volume":"86","author":"C Cunniff","year":"1991","unstructured":"C. Cunniff, K.L. Jones, K. Benirschke, Ovarian dysgenesis in individuals with chromosomal abnormalities. Hum. Genet. 86, 552\u2013556 (1991)","journal-title":"Hum. Genet."},{"key":"9569_CR18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1086\/302152","volume":"63","author":"AR Zinn","year":"1998","unstructured":"A.R. Zinn, V.S. Tonk, Z. Chen, W.L. Flejter, H.A. Gardner, R. Guerra, H. Kushner, S. Schwartz, V.P. Sybert, D.L. Van Dyke, J.L. Ross, Evidence for a Turner syndrome locus or loci at Xp11.2\u2013p22.1. Am. J. Hum. Genet. 63, 1757\u20131766 (1998). doi: 10.1086\/302152","journal-title":"Am. J. Hum. Genet."},{"key":"9569_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-2007-980220","volume":"25","author":"D Toniolo","year":"2007","unstructured":"D. Toniolo, F. Rizzolio, X chromosome and ovarian failure. Semin. Reprod. Med. 25, 264\u2013271 (2007). doi: 10.1055\/s-2007-980220","journal-title":"Semin. Reprod. Med."},{"key":"9569_CR20","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/dei495","volume":"21","author":"F Rizzolio","year":"2006","unstructured":"F. Rizzolio, S. Bione, C. Sala, M. Goegan, M. Gentile, G. Gregato, E. Rossi, T. Pramparo, O. Zuffardi, D. Toniolo, Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum. Reprod. 21, 1477\u20131483 (2006). doi: 10.1093\/humrep\/dei495","journal-title":"Hum. Reprod."},{"key":"9569_CR21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s004390050733","volume":"102","author":"RS James","year":"1998","unstructured":"R.S. James, B. Coppin, P. Dalton, N.R. Dennis, C. Mitchell, A.J. Sharp, D.H. Skuse, N.S. Thomas, P.A. Jacobs, A study of females with deletions of the short arm of the X chromosome. Hum. Genet. 102, 507\u2013516 (1998)","journal-title":"Hum. Genet."},{"key":"9569_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1399-0004.2002.610107.x","volume":"61","author":"NH Birkebaek","year":"2002","unstructured":"N.H. Birkebaek, D. Cruger, J. Hansen, J. Nielsen, G. Bruun-Petersen, Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin. Genet. 61, 35\u201339 (2002)","journal-title":"Clin. Genet."},{"key":"9569_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01403702","volume":"26","author":"MI Boechat","year":"1996","unstructured":"M.I. Boechat, S.J. Westra, B. Lippe, Normal US appearance of ovaries and uterus in four patients with Turner\u2019s syndrome and 45, X karyotype. Pediatr. Radiol. 26, 37\u201339 (1996)","journal-title":"Pediatr. Radiol."},{"key":"9569_CR24","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.fertnstert.2010.12.039","volume":"95","author":"I Bryman","year":"2011","unstructured":"I. Bryman, L. Sylven, K. Berntorp, E. Innala, I. Bergstrom, C. Hanson, M. Oxholm, K. Landin-Wilhelmsen, Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil. Steril. 95, 2507\u20132510 (2011). doi: 10.1016\/j.fertnstert.2010.12.039","journal-title":"Fertil. Steril."},{"key":"9569_CR25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/07853899908998785","volume":"31","author":"O Hovatta","year":"1999","unstructured":"O. Hovatta, Pregnancies in women with Turner\u2019s syndrome. Ann. Med. 31, 106\u2013110 (1999)","journal-title":"Ann. Med."},{"key":"9569_CR26","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1210\/jc.82.6.1810","volume":"82","author":"AM Pasquino","year":"1997","unstructured":"A.M. Pasquino, F. Passeri, I. Pucarelli, M. Segni, G. Municchi, Spontaneous pubertal development in Turner\u2019s syndrome. Italian Study Group for Turner\u2019s Syndrome. J. Clin. Endocrinol. Metab. 82, 1810\u20131813 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/AOG.0b013e3181cb5b2a","volume":"115","author":"KH Mortensen","year":"2010","unstructured":"K.H. Mortensen, M.D. Rohde, N. Uldbjerg, C.H. Gravholt, Repeated spontaneous pregnancies in 45,X Turner syndrome. Obstet. Gynecol. 115, 446\u2013449 (2010). doi: 10.1097\/AOG.0b013e3181cb5b2a","journal-title":"Obstet. Gynecol."},{"key":"9569_CR28","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.fertnstert.2011.03.085","volume":"95","author":"TN Hadnott","year":"2011","unstructured":"T.N. Hadnott, H.N. Gould, A.M. Gharib, C.A. Bondy, Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil. Steril. 95, 2251\u20132256 (2011). doi: 10.1016\/j.fertnstert.2011.03.085","journal-title":"Fertil. Steril."},{"key":"9569_CR29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2006-1374","volume":"92","author":"CA Bondy","year":"2007","unstructured":"C.A. Bondy, Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J. Clin. Endocrinol. Metab. 92, 10\u201325 (2007). doi: 10.1210\/jc.2006-1374","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/er.2006-0050","volume":"28","author":"M Schumacher","year":"2007","unstructured":"M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, E.E. Baulieu, Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr. Rev. 28, 387\u2013439 (2007). doi: 10.1210\/er.2006-0050","journal-title":"Endocr. Rev."},{"key":"9569_CR31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0015-0282(16)58350-2","volume":"65","author":"Y Yaron","year":"1996","unstructured":"Y. Yaron, Y. Ochshorn, A. Amit, I. Yovel, A. Kogosowki, J.B. Lessing, Patients with Turner\u2019s syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donation. Fertil. Steril. 65, 1249\u20131252 (1996)","journal-title":"Fertil. Steril."},{"key":"9569_CR32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/humrep\/14.2.532","volume":"14","author":"T Foudila","year":"1999","unstructured":"T. Foudila, V. Soderstrom-Anttila, O. Hovatta, Turner\u2019s syndrome and pregnancies after oocyte donation. Hum. Reprod. 14, 532\u2013535 (1999)","journal-title":"Hum. Reprod."},{"key":"9569_CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000073233","volume":"60","author":"M Snajderova","year":"2003","unstructured":"M. Snajderova, T. Mardesic, J. Lebl, H. Gerzova, L. Teslik, J. Zapletalova, The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose. Horm. Res. 60, 198\u2013204 (2003). doi: 10.1159\/000073233","journal-title":"Horm. Res."},{"key":"9569_CR34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2265.2011.03995.x","volume":"74","author":"L Cleemann","year":"2011","unstructured":"L. Cleemann, K. Holm, E. Fallentin, S.O. Skouby, H. Smedegaard, N. Moller, H. Borch-Christensen, E.M. Jeppesen, S.B. Wieslander, A.M. Andersson, A. Cohen, G.C. Hojbjerg, Uterus and ovaries in girls and young women with Turner syndrome evaluated by ultrasound and magnetic resonance imaging. Clin. Endocrinol. (Oxf.) 74, 756\u2013761 (2011). doi: 10.1111\/j.1365-2265.2011.03995.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2265.2002.01477.x","volume":"56","author":"WF Paterson","year":"2002","unstructured":"W.F. Paterson, A.S. Hollman, M.D. Donaldson, Poor uterine development in Turner syndrome with oral oestrogen therapy. Clin. Endocrinol. (Oxf.) 56, 359\u2013365 (2002)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR36","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1210\/jc.87.8.3618","volume":"87","author":"JG Hreinsson","year":"2002","unstructured":"J.G. Hreinsson, M. Otala, M. Fridstrom, B. Borgstrom, C. Rasmussen, M. Lundqvist, T. Tuuri, N. Simberg, M. Mikkola, L. Dunkel, O. Hovatta, Follicles are found in the ovaries of adolescent girls with Turner\u2019s syndrome. J. Clin. Endocrinol. Metab. 87, 3618\u20133623 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jc.2008-0708","volume":"94","author":"B Borgstrom","year":"2009","unstructured":"B. Borgstrom, J. Hreinsson, C. Rasmussen, M. Sheikhi, G. Fried, V. Keros, M. Fridstrom, O. Hovatta, Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles. J. Clin. Endocrinol. Metab. 94, 74\u201380 (2009). doi: 10.1210\/jc.2008-0708","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1651-2227.1999.tb14419.x","volume":"88","author":"ML Davenport","year":"1999","unstructured":"M.L. Davenport, N. Punyasavatsut, D. Gunther, L. Savendahl, P.W. Stewart, Turner syndrome: a pattern of early growth failure. Acta Paediatr. Suppl. 88, 118\u2013121 (1999)","journal-title":"Acta Paediatr. Suppl."},{"key":"9569_CR39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/adc.60.10.932","volume":"60","author":"AJ Lyon","year":"1985","unstructured":"A.J. Lyon, M.A. Preece, D.B. Grant, Growth curve for girls with Turner syndrome. Arch. Dis. Child. 60, 932\u2013935 (1985)","journal-title":"Arch. Dis. Child."},{"key":"9569_CR40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1096-8628(19971112)72:4<403::AID-AJMG6>3.0.CO;2-R","volume":"72","author":"CH Gravholt","year":"1997","unstructured":"C.H. Gravholt, N.R. Weis, Reference values for body proportions and body composition in adult women with Ullrich\u2013Turner syndrome. Am. J. Med. Genet. 72, 403\u2013408 (1997). doi: 10.1002\/(SICI)1096-8628(19971112)72:4<403:AID-AJMG6>3.0.CO;2-R","journal-title":"Am. J. Med. Genet."},{"key":"9569_CR41","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1651-2227.1997.tb15174.x","volume":"86","author":"C Rongen-Westerlaken","year":"1997","unstructured":"C. Rongen-Westerlaken, L. Corel, J. van den Broeck, G. Massa, J. Karlberg, K. Albertsson-Wikland, J.M. Wit, Reference values for height, height velocity and weight in Turner\u2019s syndrome. Swedish Study Group for GH treatment. Acta Paediatr. 86, 937\u2013942 (1997)","journal-title":"Acta Paediatr."},{"key":"9569_CR42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1651-2227.1994.tb18099.x","volume":"83","author":"P Rochiccioli","year":"1994","unstructured":"P. Rochiccioli, M. David, G. Malpuech, M. Colle, J.M. Limal, J. Battin, R. Mariani, C. Sultan, J.L. Nivelon, G. Simonin, Study of final height in Turner\u2019s syndrome: ethnic and genetic influences. Acta Paediatr. 83, 305\u2013308 (1994)","journal-title":"Acta Paediatr."},{"key":"9569_CR43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1651-2227.1997.tb08823.x","volume":"86","author":"LC Low","year":"1997","unstructured":"L.C. Low, C. Sham, E. Kwan, J. Karlberg, G. Tang, P.T. Cheung, H. Pang, W. Tse, B. But, C.M. Yu, S.T. Lam, Spontaneous growth in Chinese patients with Turner\u2019s syndrome and influence of karyotype. Acta Paediatr. 86, 18\u201321 (1997)","journal-title":"Acta Paediatr."},{"key":"9569_CR44","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/jc.84.12.4613","volume":"84","author":"T Kosho","year":"1999","unstructured":"T. Kosho, K. Muroya, T. Nagai, M. Fujimoto, S. Yokoya, H. Sakamoto, T. Hirano, H. Terasaki, H. Ohashi, G. Nishimura, S. Sato, N. Matsuo, T. Ogata, Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J. Clin. Endocrinol. Metab. 84, 4613\u20134621 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1203\/PDR.0b013e31821b570b","volume":"70","author":"M Westwood","year":"2011","unstructured":"M. Westwood, S.H. Tajbakhsh, K.W. Siddals, A.J. Whatmore, P.E. Clayton, Reduced pericellular sensitivity to IGF-I in fibroblasts from girls with Turner syndrome: a mechanism to impair clinical responses to GH. Pediatr. Res. 70, 25\u201330 (2011). doi: 10.1203\/PDR.0b013e31821b570b","journal-title":"Pediatr. Res."},{"key":"9569_CR46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2265.2008.03477.x","volume":"70","author":"AJ Whatmore","year":"2009","unstructured":"A.J. Whatmore, L. Patel, P.E. Clayton, A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatment. Clin. Endocrinol. (Oxf.) 70, 429\u2013434 (2009). doi: 10.1111\/j.1365-2265.2008.03477.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR47","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jc.82.4.1041","volume":"82","author":"A Barreca","year":"1997","unstructured":"A. Barreca, D. Larizza, G. Damonte, M. Arvigo, P. Ponzani, A. Cesarone, C.F. Lo, F. Severi, G. Giordano, F. Minuto, Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner\u2019s syndrome in culture. J. Clin. Endocrinol. Metab. 82, 1041\u20131046 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ghir.2006.09.001","volume":"16","author":"CH Gravholt","year":"2006","unstructured":"C.H. Gravholt, J.W. Chen, C. Oxvig, M.T. Overgaard, J.S. Christiansen, J. Frystyk, A. Flyvbjerg, The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT. Growth Horm. IGF Res. 16, 332\u2013339 (2006). doi: 10.1016\/j.ghir.2006.09.001","journal-title":"Growth Horm. IGF Res."},{"key":"9569_CR49","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/jc.84.12.4607","volume":"84","author":"TC Sas","year":"1999","unstructured":"T.C. Sas, S.M. de Muinck Keizer-Schrama, T. Stijnen, M. Jansen, B.J. Otten, J. Hoorweg-Nijman, T. Vulsma, G.G. Massa, C.W. Rouwe, H.M. Reeser, W.J. Gerver, J.J. Gosen, C. Rongen-Westerlaken, S.L. Drop, Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J. Clin. Endocrinol. Metab. 84, 4607\u20134612 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR50","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1210\/jc.83.5.1462","volume":"83","author":"JC Carel","year":"1998","unstructured":"J.C. Carel, L. Mathivon, C. Gendrel, J.P. Ducret, J.L. Chaussain, Near normalization of final height with adapted doses of growth hormone in Turner\u2019s syndrome. J. Clin. Endocrinol. Metab. 83, 1462\u20131466 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR51","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000223418","volume":"71","author":"EM Bannink","year":"2009","unstructured":"E.M. Bannink, R.L. van der Palen, P.G. Mulder, S.M. de Muinck Keizer-Schrama, Long-term follow-up of GH-treated girls with Turner syndrome: BMI, blood pressure, body proportions. Horm. Res. 71, 336\u2013342 (2009). doi: 10.1159\/000223418","journal-title":"Horm. Res."},{"key":"9569_CR52","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1210\/jc.2006-2874","volume":"92","author":"ML Davenport","year":"2007","unstructured":"M.L. Davenport, B.J. Crowe, S.H. Travers, K. Rubin, J.L. Ross, P.Y. Fechner, D.F. Gunther, C. Liu, M.E. Geffner, K. Thrailkill, C. Huseman, A.J. Zagar, C.A. Quigley, Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J. Clin. Endocrinol. Metab. 92, 3406\u20133416 (2007). doi: 10.1210\/jc.2006-2874","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR53","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.87.5.2033","volume":"87","author":"CA Quigley","year":"2002","unstructured":"C.A. Quigley, B.J. Crowe, D.G. Anglin, J.J. Chipman, Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J. Clin. Endocrinol. Metab. 87, 2033\u20132041 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1677\/joe.1.06059","volume":"185","author":"R Eastell","year":"2005","unstructured":"R. Eastell, Role of oestrogen in the regulation of bone turnover at the menarche. J. Endocrinol. 185, 223\u2013234 (2005). doi: 10.1677\/joe.1.06059","journal-title":"J. Endocrinol."},{"key":"9569_CR55","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1210\/jc.85.7.2439","volume":"85","author":"SD Chernausek","year":"2000","unstructured":"S.D. Chernausek, K.M. Attie, J.F. Cara, R.G. Rosenfeld, J. Frane, Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J. Clin. Endocrinol. Metab. 85, 2439\u20132445 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR56","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1210\/jc.2002-021171","volume":"88","author":"YK Pareren Van","year":"2003","unstructured":"Y.K. Van Pareren, S.M. de Muinck Keizer-Schrama, T. Stijnen, T.C. Sas, M. Jansen, B.J. Otten, J.J. Hoorweg-Nijman, T. Vulsma, W.H. Stokvis-Brantsma, C.W. Rouwe, H.M. Reeser, W.J. Gerver, J.J. Gosen, C. Rongen-Westerlaken, S.L. Drop, Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J. Clin. Endocrinol. Metab. 88, 1119\u20131125 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem-72-2-374","volume":"72","author":"AJ Weissberger","year":"1991","unstructured":"A.J. Weissberger, K.K. Ho, L. Lazarus, Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72, 374\u2013381 (1991)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1210\/jc.85.1.464","volume":"85","author":"YJ Janssen","year":"2000","unstructured":"Y.J. Janssen, F. Helmerhorst, M. Frolich, F. Roelfsema, A switch from oral (2\u00a0mg\/day) to transdermal (50\u00a0microg\/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J. Clin. Endocrinol. Metab. 85, 464\u2013467 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR59","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1210\/jc.2005-1081","volume":"90","author":"RL Rosenfield","year":"2005","unstructured":"R.L. Rosenfield, N. Devine, J.J. Hunold, N. Mauras, T. Moshang Jr., A.W. Root, Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 90, 6424\u20136430 (2005). doi: 10.1210\/jc.2005-1081","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR60","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1210\/jc.2005-0470","volume":"90","author":"L Soriano-Guillen","year":"2005","unstructured":"L. Soriano-Guillen, J. Coste, E. Ecosse, J. Leger, M. Tauber, S. Cabrol, M. Nicolino, R. Brauner, J.L. Chaussain, J.C. Carel, Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J. Clin. Endocrinol. Metab. 90, 5197\u20135204 (2005). doi: 10.1210\/jc.2005-0470","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR61","doi-asserted-by":"crossref","unstructured":"M. Taboada, R. Santenm, J. Lima, J. Hossain, R. Singh, K.O. Klein, N. Mauras, Pharmacokinetics and pharmacodynamics of oral and transdermal 17{beta} estradiol in girls with Turner syndrome. J. Clin. Endocrinol. Metab. (2011). doi: 10.1210\/jc.2011-1449","DOI":"10.1210\/jc.2011-1449"},{"key":"9569_CR62","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1210\/jc.82.8.2570","volume":"82","author":"CH Gravholt","year":"1997","unstructured":"C.H. Gravholt, R.W. Naeraa, S. Fisker, J.S. Christiansen, Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner\u2019s syndrome, with important modulations by treatment with 17 beta-estradiol. J. Clin. Endocrinol. Metab. 82, 2570\u20132577 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR63","doi-asserted-by":"crossref","unstructured":"E.R. Prossnitz, M. Barton, The G-protein-coupled estrogen receptor GPER in health and disease. Nat. Rev. Endocrinol. (2011). doi: 10.1038\/nrendo.2011.122","DOI":"10.1038\/nrendo.2011.122"},{"key":"9569_CR64","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1210\/jc.83.9.3198","volume":"83","author":"JL Ross","year":"1998","unstructured":"J.L. Ross, D. Roeltgen, P. Feuillan, H. Kushner, G.B. Cutler Jr., Effects of estrogen on nonverbal processing speed and motor function in girls with Turner\u2019s syndrome. J. Clin. Endocrinol. Metab. 83, 3198\u20133204 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.54.1.164","volume":"54","author":"JL Ross","year":"2000","unstructured":"J.L. Ross, D. Roeltgen, P. Feuillan, H. Kushner, G.B. Cutler Jr., Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology 54, 164\u2013170 (2000)","journal-title":"Neurology"},{"key":"9569_CR66","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1005669","volume":"364","author":"JL Ross","year":"2011","unstructured":"J.L. Ross, C.A. Quigley, D. Cao, P. Feuillan, K. Kowal, J.J. Chipman, G.B. Cutler Jr., Growth hormone plus childhood low-dose estrogen in Turner\u2019s syndrome. N. Engl. J. Med. 364, 1230\u20131242 (2011). doi: 10.1056\/NEJMoa1005669","journal-title":"N. Engl. J. Med."},{"key":"9569_CR67","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1210\/jcem-60-6-1087","volume":"60","author":"L Cuttler","year":"1985","unstructured":"L. Cuttler, V.G. Van, F.A. Conte, S.L. Kaplan, M.M. Grumbach, Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy. J. Clin. Endocrinol. Metab. 60, 1087\u20131092 (1985)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR68","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1210\/jc.84.7.2286","volume":"84","author":"P Vestergaard","year":"1999","unstructured":"P. Vestergaard, A.P. Hermann, H. Orskov, L. Mosekilde, Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study. J. Clin. Endocrinol. Metab. 84, 2286\u20132290 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR69","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","volume":"25","author":"KC Leung","year":"2004","unstructured":"K.C. Leung, G. Johannsson, G.M. Leong, K.K. Ho, Estrogen regulation of growth hormone action. Endocr. Rev. 25, 693\u2013721 (2004). doi: 10.1210\/er.2003-0035","journal-title":"Endocr. Rev."},{"key":"9569_CR70","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ghir.2008.08.009","volume":"19","author":"DS Huang","year":"2009","unstructured":"D.S. Huang, A.J. O\u2019Sullivan, Short-term oral oestrogen therapy dissociates the growth hormone\/insulin-like growth factor-I axis without altering energy metabolism in premenopausal women. Growth Horm. IGF Res. 19, 162\u2013167 (2009). doi: 10.1016\/j.ghir.2008.08.009","journal-title":"Growth Horm. IGF Res."},{"key":"9569_CR71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0015-0282(98)00432-4","volume":"71","author":"A Cano","year":"1999","unstructured":"A. Cano, C. Castelo-Branco, J.J. Tarin, Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels. Fertil. Steril. 71, 261\u2013267 (1999)","journal-title":"Fertil. Steril."},{"key":"9569_CR72","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/jcem-65-5-862","volume":"65","author":"F Bidlingmaier","year":"1987","unstructured":"F. Bidlingmaier, T.M. Strom, H.G. Dorr, W. Eisenmenger, D. Knorr, Estrone and estradiol concentrations in human ovaries, testes, and adrenals during the first two years of life. J. Clin. Endocrinol. Metab. 65, 862\u2013867 (1987)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1994.tb55784.x","volume":"743","author":"BS McEwen","year":"1994","unstructured":"B.S. McEwen, How do sex and stress hormones affect nerve cells? Ann. N Y Acad. Sci. 743, 1\u201316 (1994)","journal-title":"Ann. N Y Acad. Sci."},{"key":"9569_CR74","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-8628(19980901)79:2<140::AID-AJMG10>3.0.CO;2-J","volume":"79","author":"SM Romans","year":"1998","unstructured":"S.M. Romans, G. Stefanatos, D.P. Roeltgen, H. Kushner, J.L. Ross, Transition to young adulthood in Ullrich\u2013Turner syndrome: neurodevelopmental changes. Am. J. Med. Genet. 79, 140\u2013147 (1998). doi: 10.1002\/(SICI)1096-8628(19980901)79:2<140:AID-AJMG10>3.0.CO;2-J","journal-title":"Am. J. Med. Genet."},{"key":"9569_CR75","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/002221949102400107","volume":"24","author":"J Downey","year":"1991","unstructured":"J. Downey, E.J. Elkin, A.A. Ehrhardt, H.F. Meyer-Bahlburg, J.J. Bell, A. Morishima, Cognitive ability and everyday functioning in women with Turner syndrome. J. Learn. Disabil. 24, 32\u201339 (1991)","journal-title":"J. Learn. Disabil."},{"key":"9569_CR76","first-page":"7","volume":"4","author":"A Swillen","year":"1993","unstructured":"A. Swillen, J.P. Fryns, A. Kleczkowska, G. Massa, M. Vanderschueren-Lodeweyckx, H. Van den Berghe, Intelligence, behaviour and psychosocial development in Turner syndrome. A cross-sectional study of 50 pre-adolescent and adolescent girls (4\u201320 years). Genet. Couns. 4, 7\u201318 (1993)","journal-title":"Genet. Couns."},{"key":"9569_CR77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1749-6632.1994.tb55794.x","volume":"743","author":"BB Sherwin","year":"1994","unstructured":"B.B. Sherwin, Estrogenic effects on memory in women. Ann. N Y Acad. Sci. 743, 213\u2013230 (1994)","journal-title":"Ann. N Y Acad. Sci."},{"key":"9569_CR78","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1532-5415.1996.tb01400.x","volume":"44","author":"R Schmidt","year":"1996","unstructured":"R. Schmidt, F. Fazekas, B. Reinhart, P. Kapeller, G. Fazekas, H. Offenbacher, B. Eber, M. Schumacher, W. Freidl, ) Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J. Am. Geriatr. Soc. 44, 1307\u20131313 (1996)","journal-title":"J. Am. Geriatr. Soc."},{"key":"9569_CR79","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.50.2.368","volume":"50","author":"DM Jacobs","year":"1998","unstructured":"D.M. Jacobs, M.X. Tang, Y. Stern, M. Sano, K. Marder, K.L. Bell, P. Schofield, G. Dooneief, B. Gurland, R. Mayeux, Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50, 368\u2013373 (1998)","journal-title":"Neurology"},{"key":"9569_CR80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000090698","volume":"65","author":"J Ross","year":"2006","unstructured":"J. Ross, D. Roeltgen, A. Zinn, Cognition and the sex chromosomes: studies in Turner syndrome. Horm. Res. 65, 47\u201356 (2006). doi: 10.1159\/000090698","journal-title":"Horm. Res."},{"key":"9569_CR81","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/jc.2002-021000","volume":"88","author":"JL Ross","year":"2003","unstructured":"J.L. Ross, D. Roeltgen, G.A. Stefanatos, P. Feuillan, H. Kushner, C. Bondy, G. B. J. Cutler Jr, Androgen-responsive aspects of cognition in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 88, 292\u2013296 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR82","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jpeds.2009.05.031","volume":"155","author":"JL Ross","year":"2009","unstructured":"J.L. Ross, M.M. Mazzocco, H. Kushner, K. Kowal Jr., G.B. Cutler, D. Roeltgen, Effects of treatment with oxandrolone for 4\u00a0years on the frequency of severe arithmetic learning disability in girls with Turner syndrome. J. Pediatr. 155, 714\u2013720 (2009). doi: 10.1016\/j.jpeds.2009.05.031","journal-title":"J. Pediatr."},{"key":"9569_CR83","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yhbeh.2009.12.011","volume":"57","author":"LA Menke","year":"2010","unstructured":"L.A. Menke, T.C. Sas, M. Visser, B.P. Kreukels, T. Stijnen, G.R. Zandwijken, S.M. de Muinck Keizer-Schrama, B.J. Otten, J.M. Wit, P.T. Cohen-Kettenis, The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome. Horm. Behav. 57, 297\u2013305 (2010). doi: 10.1016\/j.yhbeh.2009.12.011","journal-title":"Horm. Behav."},{"key":"9569_CR84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1530\/acta.0.1290188","volume":"129","author":"L Sylven","year":"1993","unstructured":"L. Sylven, C. Magnusson, K. Hagenfeldt, von, S. B., Life with Turner\u2019s syndrome\u2014a psychosocial report from 22 middle-aged women. Acta Endocrinol. (Cph.) 129, 188\u2013194 (1993)","journal-title":"Acta Endocrinol. (Cph.)"},{"key":"9569_CR85","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/JPEM.2002.15.2.129","volume":"15","author":"N Stahnke","year":"2002","unstructured":"N. Stahnke, E. Keller, H. Landy, Favorable final height outcome in girls with Ullrich\u2013Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10\u00a0years of age. J. Pediatr. Endocrinol. Metab. 15, 129\u2013138 (2002)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"9569_CR86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3476(05)82540-5","volume":"121","author":"RG Rosenfeld","year":"1992","unstructured":"R.G. Rosenfeld, J. Frane, K.M. Attie, J.A. Brasel, S. Burstein, J.F. Cara, S. Chernausek, R.W. Gotlin, J. Kuntze, B.M. Lippe et al., Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J. Pediatr. 121, 49\u201355 (1992)","journal-title":"J. Pediatr."},{"key":"9569_CR87","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3476(98)70452-4","volume":"132","author":"RG Rosenfeld","year":"1998","unstructured":"R.G. Rosenfeld, K.M. Attie, J. Frane, J.A. Brasel, S. Burstein, J.F. Cara, S. Chernausek, R.W. Gotlin, J. Kuntze, B.M. Lippe, C.P. Mahoney, W.V. Moore, P. Saenger, A.J. Johanson, Growth hormone therapy of Turner\u2019s syndrome: beneficial effect on adult height. J. Pediatr. 132, 319\u2013324 (1998)","journal-title":"J. Pediatr."},{"key":"9569_CR88","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1210\/jc.81.2.635","volume":"81","author":"KO Nilsson","year":"1996","unstructured":"K.O. Nilsson, K. Albertsson-Wikland, J. Alm, S. Aronson, J. Gustafsson, L. Hagenas, A. Hager, S.A. Ivarsson, J. Karlberg, B. Kristrom, C. Marcus, C. Moell, M. Ritzen, T. Tuvemo, C. Wattsgard, U. Westgren, O. Westphal, J. Aman, Improved final height in girls with Turner\u2019s syndrome treated with growth hormone and oxandrolone. J. Clin. Endocrinol. Metab. 81, 635\u2013640 (1996)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR89","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1651-2227.1990.tb11555.x","volume":"79","author":"RW Naeraa","year":"1990","unstructured":"R.W. Naeraa, J. Nielsen, I.L. Pedersen, K. Sorensen, Effect of oxandrolone on growth and final height in Turner\u2019s syndrome. Acta Paediatr. Scand. 79, 784\u2013789 (1990)","journal-title":"Acta Paediatr. Scand."},{"key":"9569_CR90","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1651-2227.1984.tb09994.x","volume":"73","author":"E Joss","year":"1984","unstructured":"E. Joss, K. Zuppinger, Oxandrolone in girls with Turner\u2019s syndrome. A pair-matched controlled study up to final height. Acta Paediatr. Scand. 73, 674\u2013679 (1984)","journal-title":"Acta Paediatr. Scand."},{"key":"9569_CR91","first-page":"1408","volume":"85","author":"G Haeusler","year":"1996","unstructured":"G. Haeusler, K. Schmitt, P. Blumel, E. Plochl, T. Waldhor, H. Frisch, Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Acta Paediatr. 85, 1408\u20131414 (1996)","journal-title":"Acta Paediatr."},{"key":"9569_CR92","doi-asserted-by":"crossref","first-page":"d1980","DOI":"10.1136\/bmj.d1980","volume":"342","author":"EJ Gault","year":"2011","unstructured":"E.J. Gault, R.J. Perry, T.J. Cole, S. Casey, W.F. Paterson, P.C. Hindmarsh, P. Betts, D.B. Dunger, M.D. Donaldson, Effect of oxandrolone and timing of pubertal induction on final height in Turner\u2019s syndrome: randomised, double blind, placebo controlled trial. BMJ 342, d1980 (2011)","journal-title":"BMJ"},{"key":"9569_CR93","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-3476(84)81096-3","volume":"104","author":"VP Sybert","year":"1984","unstructured":"V.P. Sybert, Adult height in Turner syndrome with and without androgen therapy. J. Pediatr. 104, 365\u2013369 (1984)","journal-title":"J. Pediatr."},{"key":"9569_CR94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jc.81.2.536","volume":"81","author":"G Haeusler","year":"1996","unstructured":"G. Haeusler, K. Schmitt, P. Blumel, E. Plochl, T. Waldhor, H. Frisch, Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner\u2019s syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. J. Clin. Endocrinol. Metab. 81, 536\u2013541 (1996)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR95","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jc.2009-1821","volume":"95","author":"LA Menke","year":"2010","unstructured":"L.A. Menke, T.C. Sas, S.M. de Muinck Keizer-Schrama, G.R. Zandwijken, M.A. de Ridder, R.J. Odink, M. Jansen, H.A. Delemarre-van de Waal, W.H. Stokvis-Brantsma, J.J. Waelkens, C. Westerlaken, H.M. Reeser, A.S. van Trotsenburg, E.F. Gevers, S. van Buuren, P.H. Dejonckere, A.C. Hokken-Koelega, B.J. Otten, J.M. Wit, Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. J. Clin. Endocrinol. Metab. 95, 1151\u20131160 (2010). doi: 10.1210\/jc.2009-1821","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR96","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000319313","volume":"75","author":"LA Menke","year":"2011","unstructured":"L.A. Menke, T.C. Sas, T. Stijnen, G.R. Zandwijken, S.M. de Muinck Keizer-Schrama, B.J. Otten, J.M. Wit, Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome. Horm. Res. Paediatr. 75, 115\u2013122 (2011). doi: 10.1159\/000319313","journal-title":"Horm. Res. Paediatr."},{"key":"9569_CR97","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000317529","volume":"75","author":"MP Zeger","year":"2011","unstructured":"M.P. Zeger, K. Shah, K. Kowal Jr., G.B. Cutler, H. Kushner, J.L. Ross, Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome. Horm. Res. Paediatr. 75, 38\u201346 (2011). doi: 10.1159\/000317529","journal-title":"Horm. Res. Paediatr."},{"key":"9569_CR98","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1210\/jc.2009-0514","volume":"94","author":"N Zuckerman-Levin","year":"2009","unstructured":"N. Zuckerman-Levin, T. Frolova-Bishara, D. Militianu, M. Levin, J. Aharon-Peretz, Z. Hochberg, Androgen replacement therapy in Turner syndrome: a pilot study. J. Clin. Endocrinol. Metab. 94, 4820\u20134827 (2009). doi: 10.1210\/jc.2009-0514","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR99","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1651-2227.1994.tb18144.x","volume":"83","author":"G Andersson-Wallgren","year":"1994","unstructured":"G. Andersson-Wallgren, K. Albertsson-Wikland, Change in speaking fundamental frequency in hormone-treated patients with Turner\u2019s syndrome\u2014a longitudinal study of four cases. Acta Paediatr. 83, 452\u2013455 (1994)","journal-title":"Acta Paediatr."},{"key":"9569_CR100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2265.2010.03789.x","volume":"73","author":"LA Menke","year":"2010","unstructured":"L.A. Menke, T.C. Sas, G.R. Zandwijken, M.A. de Ridde, T. Stijnen, S.M. de MuinckKeizer-Schrama, B.J. Otten, J.M. Wit, The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome. Clin. Endocrinol. (Oxf.) 73, 212\u2013219 (2010). doi: 10.1111\/j.1365-2265.2010.03789.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR101","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2265.1995.tb00544.x","volume":"43","author":"MC Davies","year":"1995","unstructured":"M.C. Davies, B. Gulekli, H.S. Jacobs, Osteoporosis in Turner\u2019s syndrome and other forms of primary amenorrhoea. Clin. Endocrinol. (Oxf.) 43, 741\u2013746 (1995)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR102","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jcem-73-2-355","volume":"73","author":"JL Ross","year":"1991","unstructured":"J.L. Ross, L.M. Long, P. Feuillan, F. Cassorla, G.B. Cutler Jr., Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner\u2019s syndrome. J. Clin. Endocrinol. Metab. 73, 355\u2013359 (1991)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2265.2007.02835.x","volume":"67","author":"N Zuckerman-Levin","year":"2007","unstructured":"N. Zuckerman-Levin, I. Yaniv, T. Schwartz, H. Guttmann, Z. Hochberg, Normal DXA bone mineral density but frail cortical bone in Turner\u2019s syndrome. Clin. Endocrinol. (Oxf.) 67, 60\u201364 (2007). doi: 10.1111\/j.1365-2265.2007.02835.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR104","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1210\/jc.2003-030913","volume":"88","author":"VK Bakalov","year":"2003","unstructured":"V.K. Bakalov, L. Axelrod, J. Baron, L. Hanton, L.M. Nelson, J.C. Reynolds, S. Hill, J. Troendle, C.A. Bondy, Selective reduction in cortical bone mineral density in turner syndrome independent of ovarian hormone deficiency. J. Clin. Endocrinol. Metab. 88, 5717\u20135722 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR105","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1210\/jc.87.6.2798","volume":"87","author":"CH Gravholt","year":"2002","unstructured":"C.H. Gravholt, A.L. Lauridsen, K. Brixen, L. Mosekilde, L. Heickendorff, J.S. Christiansen, Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study. J. Clin. Endocrinol. Metab. 87, 2798\u20132808 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR106","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02565125","volume":"49","author":"RW Naeraa","year":"1991","unstructured":"R.W. Naeraa, K. Brixen, R.M. Hansen, C. Hasling, L. Mosekilde, J.H. Andresen, P. Charles, J. Nielsen, Skeletal size and bone mineral content in Turner\u2019s syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover. Calcif. Tissue Int. 49, 77\u201383 (1991)","journal-title":"Calcif. Tissue Int."},{"key":"9569_CR107","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1359\/jbmr.2000.15.10.2005","volume":"15","author":"A Carrascosa","year":"2000","unstructured":"A. Carrascosa, M. Gussinye, P. Terradas, D. Yeste, L. Audi, E. Vicens-Calvet, Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J. Bone Miner. Res. 15, 2005\u20132010 (2000). doi: 10.1359\/jbmr.2000.15.10.2005","journal-title":"J. Bone Miner. Res."},{"key":"9569_CR108","first-page":"585","volume":"76","author":"SJ Emans","year":"1990","unstructured":"S.J. Emans, E. Grace, F.A. Hoffer, C. Gundberg, V. Ravnikar, E.R. Woods, Estrogen deficiency in adolescents and young adults: impact on bone mineral content and effects of estrogen replacement therapy. Obstet. Gynecol. 76, 585\u2013592 (1990)","journal-title":"Obstet. Gynecol."},{"key":"9569_CR109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01623938","volume":"6","author":"JP Sabatier","year":"1996","unstructured":"J.P. Sabatier, G. Guaydier-Souquieres, D. Laroche, A. Benmalek, L. Fournier, F. Guillon-Metz, J. Delavenne, A.Y. Denis, Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10\u201324\u00a0years of age. Osteoporos. Int. 6, 141\u2013148 (1996)","journal-title":"Osteoporos. Int."},{"key":"9569_CR110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jadohealth.2006.08.013","volume":"40","author":"Z Harel","year":"2007","unstructured":"Z. Harel, M. Gold, B. Cromer, A. Bruner, M. Stager, L. Bachrach, K. Wolter, C. Reid, P. Hertweck, A. Nelson, D. Nelson, S. Coupey, C. Johnson, R. Burkman, H. Bone, Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers. J. Adolesc. Health 40, 44\u201353 (2007). doi: 10.1016\/j.jadohealth.2006.08.013","journal-title":"J. Adolesc. Health"},{"key":"9569_CR111","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0022-3476(74)80755-9","volume":"84","author":"DM Brown","year":"1974","unstructured":"D.M. Brown, J. Jowsey, D.S. Bradford, Osteoporosis in ovarian dysgenesis. J. Pediatr. 84, 816\u2013820 (1974)","journal-title":"J. Pediatr."},{"key":"9569_CR112","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2265.1996.00849.x","volume":"45","author":"AS Garden","year":"1996","unstructured":"A.S. Garden, M.J. Diver, W.D. Fraser, Undiagnosed morbidity in adult women with Turner\u2019s syndrome. Clin. Endocrinol. (Oxf.) 45, 589\u2013593 (1996)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR113","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1259\/bjr.71.849.10195008","volume":"71","author":"S Pors Nielsen","year":"1998","unstructured":"S. Pors Nielsen, N. Kolthoff, O. Barenholdt, B. Kristensen, B. Abrahamsen, A.P. Hermann, C. Brot, Diagnosis of osteoporosis by planar bone densitometry: can body size be disregarded? Br. J. Radiol. 71, 934\u2013943 (1998)","journal-title":"Br. J. Radiol."},{"key":"9569_CR114","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF02411296","volume":"34","author":"RM Shore","year":"1982","unstructured":"R.M. Shore, R.W. Chesney, R.B. Mazess, P.G. Rose, G.J. Bargman, Skeletal demineralization in Turner\u2019s syndrome. Calcif. Tissue Int. 34, 519\u2013522 (1982)","journal-title":"Calcif. Tissue Int."},{"key":"9569_CR115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jbmr.5650040210","volume":"4","author":"JJ Stepan","year":"1989","unstructured":"J.J. Stepan, J. Musilova, V. Pacovsky, Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner\u2019s syndrome. J. Bone Miner. Res. 4, 193\u2013198 (1989). doi: 10.1002\/jbmr.5650040210","journal-title":"J. Bone Miner. Res."},{"key":"9569_CR116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/eje.0.1320047","volume":"132","author":"L Sylven","year":"1995","unstructured":"L. Sylven, K. Hagenfeldt, H. Ringertz, Bone mineral density in middle-aged women with Turner\u2019s syndrome. Eur. J. Endocrinol. 132, 47\u201352 (1995)","journal-title":"Eur. J. Endocrinol."},{"key":"9569_CR117","first-page":"747","volume":"79","author":"S Mora","year":"1992","unstructured":"S. Mora, G. Weber, M.P. Guarneri, G. Nizzoli, D. Pasolini, G. Chiumello, Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome. Obstet. Gynecol. 79, 747\u2013751 (1992)","journal-title":"Obstet. Gynecol."},{"key":"9569_CR118","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(97)90078-0","volume":"46","author":"N Mauras","year":"1997","unstructured":"N. Mauras, N.E. Vieira, A.L. Yergey, Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner\u2019s syndrome: a calcium kinetic study. Metabolism 46, 908\u2013913 (1997)","journal-title":"Metabolism"},{"key":"9569_CR119","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000023517","volume":"53","author":"S Bertelloni","year":"2000","unstructured":"S. Bertelloni, L. Cinquanta, G.I. Baroncelli, P. Simi, S. Rossi, G. Saggese, Volumetric bone mineral density in young women with Turner\u2019s syndrome treated with estrogens or estrogens plus growth hormone. Horm. Res. 53, 72\u201376 (2000)","journal-title":"Horm. Res."},{"key":"9569_CR120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1203\/00006450-200109000-00019","volume":"50","author":"TC Sas","year":"2001","unstructured":"T.C. Sas, S.M. de Muinck Keizer-Schrama, T. Stijnen, A. van Teunenbroek, W.J. van Leeuwen, A. Asarfi, R.R. van Rijn, S.L. Drop, Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner\u2019s syndrome participating in a randomized dose-response study. Pediatr. Res. 50, 417\u2013422 (2001)","journal-title":"Pediatr. Res."},{"key":"9569_CR121","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jc.2003-030799","volume":"89","author":"W Hogler","year":"2004","unstructured":"W. Hogler, J. Briody, B. Moore, S. Garnett, P.W. Lu, C.T. Cowell, Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J. Clin. Endocrinol. Metab. 89, 193\u2013199 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR122","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.2010.03955.x","volume":"74","author":"O Soucek","year":"2011","unstructured":"O. Soucek, J. Lebl, M. Snajderova, S. Kolouskova, M. Rocek, Z. Hlavka, O. Cinek, J. Rittweger, Z. Sumnik, Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages. Clin. Endocrinol. (Oxf.) 74, 445\u2013452 (2011). doi: 10.1111\/j.1365-2265.2010.03955.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR123","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jmg.19.2.100","volume":"19","author":"MA Smith","year":"1982","unstructured":"M.A. Smith, J. Wilson, W.H. Price, Bone demineralisation in patients with Turner\u2019s syndrome. J. Med. Genet. 19, 100\u2013103 (1982)","journal-title":"J. Med. Genet."},{"key":"9569_CR124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0002-9343(03)00364-4","volume":"115","author":"VK Bakalov","year":"2003","unstructured":"V.K. Bakalov, M.L. Chen, J. Baron, L.B. Hanton, J.C. Reynolds, C.A. Stratakis, L.E. Axelrod, C.A. Bondy, Bone mineral density and fractures in Turner syndrome. Am. J. Med. 115, 259\u2013264 (2003)","journal-title":"Am. J. Med."},{"key":"9569_CR125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2265.2006.02643.x","volume":"65","author":"TS Han","year":"2006","unstructured":"T.S. Han, B. Cadge, G.S. Conway, Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner\u2019s syndrome. Clin. Endocrinol. (Oxf.) 65, 643\u2013647 (2006). doi: 10.1111\/j.1365-2265.2006.02643.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR126","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-010-1375-2","volume":"22","author":"P Pitukcheewanont","year":"2011","unstructured":"P. Pitukcheewanont, N. Numbenjapon, D. Safani, S. Rossmiller, V. Gilsanz, G. Costin, Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy. Osteoporos. Int. 22, 1709\u20131715 (2011). doi: 10.1007\/s00198-010-1375-2","journal-title":"Osteoporos. Int."},{"key":"9569_CR127","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-2265.2007.02984.x","volume":"67","author":"N Nissen","year":"2007","unstructured":"N. Nissen, C.H. Gravholt, B. Abrahamsen, E.M. Hauge, J.E. Jensen, L. Mosekilde, K. Brixen, Disproportional geometry of the proximal femur in patients with Turner syndrome: a cross-sectional study. Clin. Endocrinol. (Oxf.) 67, 897\u2013903 (2007). doi: 10.1111\/j.1365-2265.2007.02984.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR128","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1210\/jc.86.12.5819","volume":"86","author":"S Bechtold","year":"2001","unstructured":"S. Bechtold, F. Rauch, V. Noelle, S. Donhauser, C.M. Neu, E. Schoenau, H.P. Schwarz, Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J. Clin. Endocrinol. Metab. 86, 5819\u20135823 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.2004.01951.x","volume":"60","author":"F Buzi","year":"2004","unstructured":"F. Buzi, G. Maccarinelli, B. Guaragni, F. Ruggeri, G. Radetti, A. Meini, E. Mazzolari, D. Cocchi, Serum osteoprotegerin and receptor activator of nuclear factors kB (RANKL) concentrations in normal children and in children with pubertal precocity, Turner\u2019s syndrome and rheumatoid arthritis. Clin. Endocrinol. (Oxf.) 60, 87\u201391 (2004)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1359\/jbmr.2003.18.5.925","volume":"18","author":"G Khastgir","year":"2003","unstructured":"G. Khastgir, J.W. Studd, S.W. Fox, J. Jones, J. Alaghband-Zadeh, J.W. Chow, A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner\u2019s syndrome. J. Bone Miner. Res. 18, 925\u2013932 (2003). doi: 10.1359\/jbmr.2003.18.5.925","journal-title":"J. Bone Miner. Res."},{"key":"9569_CR131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-09-0020","volume":"161","author":"L Cleemann","year":"2009","unstructured":"L. Cleemann, B.E. Hjerrild, A.L. Lauridsen, L. Heickendorff, J.S. Christiansen, L. Mosekilde, C.H. Gravholt, Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. Eur. J. Endocrinol. 161, 251\u2013257 (2009). doi: 10.1530\/EJE-09-0020","journal-title":"Eur. J. Endocrinol."},{"key":"9569_CR132","doi-asserted-by":"crossref","unstructured":"L. Cleemann, K. Holm, H. Kobbernagel, S.O., Skouby, B., Kristensen, H., Smedegaard, A.M., Andersson, A., Cohen, C.H. Gravholt, Normal tempo of bone formation in Turner syndrome despite signs of accelerated bone resorption. Horm. Res. Paediatr. (2011). doi: 10.1159\/000329046","DOI":"10.1159\/000329046"},{"key":"9569_CR133","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1359\/jbmr.1999.14.9.1473","volume":"14","author":"HM Frost","year":"1999","unstructured":"H.M. Frost, On the estrogen\u2013bone relationship and postmenopausal bone loss: a new model. J. Bone Miner. Res. 14, 1473\u20131477 (1999). doi: 10.1359\/jbmr.1999.14.9.1473","journal-title":"J. Bone Miner. Res."},{"key":"9569_CR134","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.2009.03686.x","volume":"72","author":"W Hogler","year":"2010","unstructured":"W. Hogler, N. Shaw, Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin. Endocrinol. (Oxf.) 72, 281\u2013289 (2010). doi: 10.1111\/j.1365-2265.2009.03686.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jbmr.5650030613","volume":"3","author":"JR Buchanan","year":"1988","unstructured":"J.R. Buchanan, C. Myers, T. Lloyd, P. Leuenberger, L.M. Demers, Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise. J. Bone Miner. Res. 3, 673\u2013680 (1988). doi: 10.1002\/jbmr.5650030613","journal-title":"J. Bone Miner. Res."},{"key":"9569_CR136","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1210\/jc.2004-0122","volume":"89","author":"VK Bakalov","year":"2004","unstructured":"V.K. Bakalov, M.M. Cooley, M.J. Quon, M.L. Luo, J.A. Yanovski, L.M. Nelson, G. Sullivan, C.A. Bondy, Impaired insulin secretion in the Turner metabolic syndrome. J. Clin. Endocrinol. Metab. 89, 3516\u20133520 (2004). doi: 10.1210\/jc.2004-0122","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR137","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1530\/EJE-11-0002","volume":"164","author":"R Giordano","year":"2011","unstructured":"R. Giordano, D. Forno, F. Lanfranco, C. Manieri, L. Ghizzoni, E. Ghigo, Metabolic and cardiovascular outcomes in a group of adult patients with Turner\u2019s syndrome under hormonal replacement therapy. Eur. J. Endocrinol. 164, 819\u2013826 (2011). doi: 10.1530\/EJE-11-0002","journal-title":"Eur. J. Endocrinol."},{"key":"9569_CR138","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/diacare.21.7.1062","volume":"21","author":"CH Gravholt","year":"1998","unstructured":"C.H. Gravholt, R.W. Naeraa, B. Nyholm, L.U. Gerdes, E. Christiansen, O. Schmitz, J.S. Christiansen, Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner\u2019s syndrome. The impact of sex hormone replacement. Diabetes Care 21, 1062\u20131070 (1998)","journal-title":"Diabetes Care"},{"key":"9569_CR139","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF02000780","volume":"153","author":"RW Holl","year":"1994","unstructured":"R.W. Holl, D. Kunze, H. Etzrodt, W. Teller, E. Heinze, Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. Eur. J. Pediatr. 153, 11\u201316 (1994)","journal-title":"Eur. J. Pediatr."},{"key":"9569_CR140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/eje.0.1510657","volume":"151","author":"CH Gravholt","year":"2004","unstructured":"C.H. Gravholt, Epidemiological, endocrine and metabolic features in Turner syndrome. Eur. J. Endocrinol. 151, 657\u2013687 (2004)","journal-title":"Eur. J. Endocrinol."},{"key":"9569_CR141","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1210\/jcem-72-4-832","volume":"72","author":"S Caprio","year":"1991","unstructured":"S. Caprio, S. Boulware, M. Diamond, R.S. Sherwin, T.O. Carpenter, K. Rubin, S. Amiel, M. Press, W.V. Tamborlane, Insulin resistance: an early metabolic defect of Turner\u2019s syndrome. J. Clin. Endocrinol. Metab. 72, 832\u2013836 (1991)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR142","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6823-11-6","volume":"11","author":"BE Hjerrild","year":"2011","unstructured":"B.E. Hjerrild, J.J. Holst, C.B. Juhl, J.S. Christiansen, O. Schmitz, C.H. Gravholt, Delayed beta-cell response and glucose intolerance in young women with Turner syndrome. BMC Endocr. Disord. 11, 6 (2011). doi: 10.1186\/1472-6823-11-6","journal-title":"BMC Endocr. Disord."},{"key":"9569_CR143","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1530\/acta.0.1250359","volume":"125","author":"L Sylven","year":"1991","unstructured":"L. Sylven, K. Hagenfeldt, K. Brondum-Nielsen, B. von Schoultz, Middle-aged women with Turner\u2019s syndrome. Medical status, hormonal treatment and social life. Acta Endocrinol. (Cph.) 125, 359\u2013365 (1991)","journal-title":"Acta Endocrinol. (Cph.)"},{"key":"9569_CR144","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2007.03166.x","volume":"68","author":"M El-Mansoury","year":"2008","unstructured":"M. El-Mansoury, K. Berntorp, I. Bryman, C. Hanson, E. Innala, A. Karlsson, K. Landin-Wilhelmsen, Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clin. Endocrinol. (Oxf.) 68, 485\u2013490 (2008). doi: 10.1111\/j.1365-2265.2007.03166.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR145","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM198606193142505","volume":"314","author":"RJ Chetkowski","year":"1986","unstructured":"R.J. Chetkowski, D.R. Meldrum, K.A. Steingold, D. Randle, J.K. Lu, P. Eggena, J.M. Hershman, N.K. Alkjaersig, A.P. Fletcher, H.L. Judd, Biologic effects of transdermal estradiol. N. Engl. J. Med. 314, 1615\u20131620 (1986). doi: 10.1056\/NEJM198606193142505","journal-title":"N. Engl. J. Med."},{"key":"9569_CR146","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/JPEM.1995.8.2.111","volume":"8","author":"N Jospe","year":"1995","unstructured":"N. Jospe, C.C. Orlowski, R.W. Furlanetto, Comparison of transdermal and oral estrogen therapy in girls with Turner\u2019s syndrome. J. Pediatr. Endocrinol. Metab. 8, 111\u2013116 (1995)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"9569_CR147","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2265.2001.01181.x","volume":"54","author":"H Guttmann","year":"2001","unstructured":"H. Guttmann, Z. Weiner, E. Nikolski, S. Ish-Shalom, J. Itskovitz-Eldor, M. Aviram, S. Reisner, Z. Hochberg, Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin. Endocrinol. (Oxf.) 54, 159\u2013164 (2001)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR148","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2265.2008.03203.x","volume":"69","author":"O Koulouri","year":"2008","unstructured":"O. Koulouri, J. Ostberg, G.S. Conway, Liver dysfunction in Turner\u2019s syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin. Endocrinol. (Oxf.) 69, 306\u2013310 (2008). doi: 10.1111\/j.1365-2265.2008.03203.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR149","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2265.2001.01321.x","volume":"55","author":"M Elsheikh","year":"2001","unstructured":"M. Elsheikh, H.J. Hodgson, J.A. Wass, G.S. Conway, Hormone replacement therapy may improve hepatic function in women with Turner\u2019s syndrome. Clin. Endocrinol. (Oxf.) 55, 227\u2013231 (2001)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ghir.2009.07.001","volume":"20","author":"C Host","year":"2010","unstructured":"C. Host, J.J. Christiansen, J.S. Christiansen, J.O. Jorgensen, C.H. Gravholt, Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes. Growth Horm. IGF Res. 20, 26\u201330 (2010). doi: 10.1016\/j.ghir.2009.07.001","journal-title":"Growth Horm. IGF Res."},{"key":"9569_CR151","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","volume":"65","author":"J McKenzie","year":"2006","unstructured":"J. McKenzie, B.M. Fisher, A.J. Jaap, A. Stanley, K. Paterson, N. Sattar, Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin. Endocrinol. (Oxf.) 65, 40\u201344 (2006). doi: 10.1111\/j.1365-2265.2006.02543.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR152","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-07-0070","volume":"156","author":"CH Gravholt","year":"2007","unstructured":"C.H. Gravholt, H.E. Poulsen, P. Ott, J.S. Christiansen, H. Vilstrup, Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. Eur. J. Endocrinol. 156, 679\u2013686 (2007). doi: 10.1530\/EJE-07-0070","journal-title":"Eur. J. Endocrinol."},{"key":"9569_CR153","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.20026","volume":"39","author":"D Roulot","year":"2004","unstructured":"D. Roulot, C. Degott, O. Chazouilleres, F. Oberti, P. Cales, N. Carbonell, S. Benferhat, S. Bresson-Hadni, D. Valla, Vascular involvement of the liver in Turner\u2019s syndrome. Hepatology 39, 239\u2013247 (2004). doi: 10.1002\/hep.20026","journal-title":"Hepatology"},{"key":"9569_CR154","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/CS20000271","volume":"101","author":"S Sipila","year":"2001","unstructured":"S. Sipila, D.R. Taaffe, S. Cheng, J. Puolakka, J. Toivanen, H. Suominen, Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin. Sci. (Lond.) 101, 147\u2013157 (2001)","journal-title":"Clin. Sci. (Lond.)"},{"key":"9569_CR155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/cs0840095","volume":"84","author":"SK Phillips","year":"1993","unstructured":"S.K. Phillips, K.M. Rook, N.C. Siddle, S.A. Bruce, R.C. Woledge, Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin. Sci. (Lond.) 84, 95\u201398 (1993)","journal-title":"Clin. Sci. (Lond.)"},{"key":"9569_CR156","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.1.02267","volume":"155","author":"CH Gravholt","year":"2006","unstructured":"C.H. Gravholt, B.E. Hjerrild, L. Mosekilde, T.K. Hansen, L.M. Rasmussen, J. Frystyk, A. Flyvbjerg, J.S. Christiansen, Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur. J. Endocrinol. 155, 583\u2013592 (2006). doi: 10.1530\/eje.1.02267","journal-title":"Eur. J. Endocrinol."},{"key":"9569_CR157","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, J. Ockene, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288, 321\u2013333 (2002)","journal-title":"JAMA"},{"key":"9569_CR158","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, H. Black, D. Bonds, R. Brunner, R. Brzyski, B. Caan, R. Chlebowski, D. Curb, M. Gass, J. Hays, G. Heiss, S. Hendrix, B.V. Howard, J. Hsia, A. Hubbell, R. Jackson, K.C. Johnson, H. Judd, J.M. Kotchen, L. Kuller, A.Z. LaCroix, D. Lane, R.D. Langer, N. Lasser, C.E. Lewis, J. Manson, K. Margolis, J. Ockene, M.J. O\u2019Sullivan, L. Phillips, R.L. Prentice, C. Ritenbaugh, J. Robbins, J.E. Rossouw, G. Sarto, M.L. Stefanick, H.L. Van, J. Wactawski-Wende, R. Wallace, S. Wassertheil-Smoller, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA 291, 1701\u20131712 (2004). doi: 10.1001\/jama.291.14.1701","journal-title":"JAMA"},{"key":"9569_CR159","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/er.2005-0020","volume":"27","author":"JL Turgeon","year":"2006","unstructured":"J.L. Turgeon, M.C. Carr, P.M. Maki, M.E. Mendelsohn, P.M. Wise, Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr. Rev. 27, 575\u2013605 (2006). doi: 10.1210\/er.2005-0020","journal-title":"Endocr. Rev."},{"key":"9569_CR160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjmed.2010.09.021","volume":"124","author":"SM Harman","year":"2011","unstructured":"S.M. Harman, E. Vittinghoff, E.A. Brinton, M.J. Budoff, M.I. Cedars, R.A. Lobo, G.R. Merriam, V.M. Miller, F. Naftolin, L. Pal, N. Santoro, H.S. Taylor, D.M. Black, Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am. J. Med. 124, 199\u2013205 (2011). doi: 10.1016\/j.amjmed.2010.09.021","journal-title":"Am. J. Med."},{"key":"9569_CR161","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(94)91117-7","volume":"343","author":"MN Sack","year":"1994","unstructured":"M.N. Sack, D.J. Rader, R.O. Cannon III, Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343, 269\u2013270 (1994)","journal-title":"Lancet"},{"key":"9569_CR162","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.CIR.89.4.1501","volume":"89","author":"DW Losordo","year":"1994","unstructured":"D.W. Losordo, M. Kearney, E.A. Kim, J. Jekanowski, J.M. Isner, Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89, 1501\u20131510 (1994)","journal-title":"Circulation"},{"key":"9569_CR163","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","volume":"24","author":"K Komukai","year":"2010","unstructured":"K. Komukai, S. Mochizuki, M. Yoshimura, Gender and the renin-angiotensin-aldosterone system. Fundam. Clin. Pharmacol. 24, 687\u2013698 (2010). doi: 10.1111\/j.1472-8206.2010.00854.x","journal-title":"Fundam. Clin. Pharmacol."},{"key":"9569_CR164","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2265.2000.00960.x","volume":"52","author":"NC Nathwani","year":"2000","unstructured":"N.C. Nathwani, R. Unwin, C.G. Brook, P.C. Hindmarsh, Blood pressure and Turner syndrome. Clin. Endocrinol. (Oxf.) 52, 363\u2013370 (2000)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR165","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000232495","volume":"72","author":"KH Mortensen","year":"2009","unstructured":"K.H. Mortensen, K.W. Hansen, M. Erlandsen, J.S. Christiansen, C.H. Gravholt, Ambulatory arterial stiffness index in Turner syndrome: the impact of sex hormone replacement therapy. Horm. Res. 72, 184\u2013189 (2009). doi: 10.1159\/000232495","journal-title":"Horm. Res."},{"key":"9569_CR166","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2265.2007.02772.x","volume":"66","author":"JE Ostberg","year":"2007","unstructured":"J.E. Ostberg, C. Storry, A.E. Donald, M.J. Attar, J.P. Halcox, G.S. Conway, A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin. Endocrinol. (Oxf.) 66, 557\u2013564 (2007). doi: 10.1111\/j.1365-2265.2007.02772.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR167","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.md.0000205629.16302.bc","volume":"85","author":"CA Bondy","year":"2006","unstructured":"C.A. Bondy, P.L. Van, V.K. Bakalov, V. Sachdev, C.A. Malone, V.B. Ho, D.R. Rosing, Prolongation of the cardiac QTc interval in Turner syndrome. Medicine 85, 75\u201381 (2006). doi: 10.1097\/01.md.0000205629.16302.bc","journal-title":"Medicine"},{"key":"9569_CR168","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00431-006-0194-0","volume":"165","author":"PR Dalla","year":"2006","unstructured":"P.R. Dalla, S. Bechtold, S. Kaab, M. Buckl, S. Urschel, H. Netz, H.P. Schwarz, QTc interval prolongation in children with Ulrich\u2013Turner syndrome. Eur. J. Pediatr. 165, 831\u2013837 (2006). doi: 10.1007\/s00431-006-0194-0","journal-title":"Eur. J. Pediatr."},{"key":"9569_CR169","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/aje\/kwr172","volume":"174","author":"Y Zhang","year":"2011","unstructured":"Y. Zhang, P. Ouyang, W.S. Post, D. Dalal, D. Vaidya, E. Blasco-Colmenares, E.Z. Soliman, G.F. Tomaselli, E. Guallar, Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third national health and nutrition examination survey and the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 174, 403\u2013411 (2011). doi: 10.1093\/aje\/kwr172","journal-title":"Am. J. Epidemiol."},{"key":"9569_CR170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/aje\/kwr170","volume":"174","author":"C van Noord","year":"2011","unstructured":"C. van Noord, E.M. Rodenburg, B.H. Striker, Invited commentary: sex-steroid hormones and QT-interval duration. Am. J. Epidemiol. 174, 412\u2013415 (2011). doi: 10.1093\/aje\/kwr170","journal-title":"Am. J. Epidemiol."},{"key":"9569_CR171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-2952(01)00611-6","volume":"62","author":"YM Shuba","year":"2001","unstructured":"Y.M. Shuba, V.E. Degtiar, V.N. Osipenko, V.G. Naidenov, R.L. Woosley, Testosterone-mediated modulation of HERG blockade by proarrhythmic agents. Biochem. Pharmacol. 62, 41\u201349 (2001)","journal-title":"Biochem. Pharmacol."},{"key":"9569_CR172","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.27270","volume":"62","author":"KT Jorgensen","year":"2010","unstructured":"K.T. Jorgensen, K. Rostgaard, I. Bache, R.J. Biggar, N.M. Nielsen, N. Tommerup, M. Frisch, Autoimmune diseases in women with Turner\u2019s syndrome. Arthritis Rheum. 62, 658\u2013666 (2010). doi: 10.1002\/art.27270","journal-title":"Arthritis Rheum."},{"key":"9569_CR173","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2249.2009.03895.x","volume":"156","author":"KH Mortensen","year":"2009","unstructured":"K.H. Mortensen, L. Cleemann, B.E. Hjerrild, E. Nexo, H. Locht, E.M. Jeppesen, C.H. Gravholt, Increased prevalence of autoimmunity in Turner syndrome\u2014influence of age. Clin. Exp. Immunol. 156, 205\u2013210 (2009). doi: 10.1111\/j.1365-2249.2009.03895.x","journal-title":"Clin. Exp. Immunol."},{"key":"9569_CR174","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2265.2001.01296.x","volume":"55","author":"M Elsheikh","year":"2001","unstructured":"M. Elsheikh, J.A. Wass, G.S. Conway, Autoimmune thyroid syndrome in women with Turner\u2019s syndrome\u2014the association with karyotype. Clin. Endocrinol. (Oxf.) 55, 223\u2013226 (2001)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9569_CR175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/BOR.0b013e328277ef2a","volume":"19","author":"AB Pernis","year":"2007","unstructured":"A.B. Pernis, Estrogen and CD4+\u00a0T cells. Curr. Opin. Rheumatol. 19, 414\u2013420 (2007). doi: 10.1097\/BOR.0b013e328277ef2a","journal-title":"Curr. Opin. Rheumatol."},{"key":"9569_CR176","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","volume":"28","author":"RH Straub","year":"2007","unstructured":"R.H. Straub, The complex role of estrogens in inflammation. Endocr. Rev. 28, 521\u2013574 (2007). doi: 10.1210\/er.2007-0001","journal-title":"Endocr. Rev."},{"key":"9569_CR177","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2431-11-49","volume":"11","author":"SP Taback","year":"2011","unstructured":"S.P. Taback, V.G. Van, Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone. BMC Pediatr. 11, 49 (2011). doi: 10.1186\/1471-2431-11-49","journal-title":"BMC Pediatr."},{"key":"9569_CR178","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/jpem.2010.075","volume":"23","author":"L Lasaite","year":"2010","unstructured":"L. Lasaite, D. Lasiene, L. Lasas, Cognition, emotions and quality of life in Lithuanian girls with Turner syndrome after growth hormone therapy discontinuation. J. Pediatr. Endocrinol. Metab. 23, 443\u2013450 (2010)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"9569_CR179","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1210\/jc.2009-1754","volume":"95","author":"E Amundson","year":"2010","unstructured":"E. Amundson, U.W. Boman, M.L. Barrenas, I. Bryman, K. Landin-Wilhelmsen, Impact of growth hormone therapy on quality of life in adults with turner syndrome. J. Clin. Endocrinol. Metab. 95, 1355\u20131359 (2010). doi: 10.1210\/jc.2009-1754","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR180","doi-asserted-by":"crossref","unstructured":"L. Baxter, J. Bryant, C.B. Cave, R. Milne, Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst. Rev. CD003887 (2007). doi: 10.1002\/14651858.CD003887.pub2","DOI":"10.1002\/14651858.CD003887.pub2"},{"key":"9569_CR181","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3181\/00379727-217-44199","volume":"217","author":"BR Bhavnani","year":"1998","unstructured":"B.R. Bhavnani, Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc. Soc. Exp. Biol. Med. 217, 6\u201316 (1998)","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"9569_CR182","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/JPEM.2006.19.1.55","volume":"19","author":"S Drobac","year":"2006","unstructured":"S. Drobac, K. Rubin, A.D. Rogol, R.L. Rosenfield, A workshop on pubertal hormone replacement options in the United States. J. Pediatr. Endocrinol. Metab. 19, 55\u201364 (2006)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"Suppl A","key":"9569_CR183","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.ghir.2006.04.002","volume":"16","author":"ML Davenport","year":"2006","unstructured":"M.L. Davenport, Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome. Growth Horm. IGF Res. 16(Suppl A), S91\u2013S97 (2006). doi: 10.1016\/j.ghir.2006.04.002","journal-title":"Growth Horm. IGF Res."},{"key":"9569_CR184","doi-asserted-by":"crossref","first-page":"E308","DOI":"10.1152\/ajpendo.2001.280.2.E308","volume":"280","author":"CH Gravholt","year":"2001","unstructured":"C.H. Gravholt, J. Frystyk, A. Flyvbjerg, H. Orskov, J.S. Christiansen, Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. Am. J. Physiol. Endocrinol. Metab. 280, E308\u2013E314 (2001)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"9569_CR185","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1210\/jc.2007-0671","volume":"92","author":"N Mauras","year":"2007","unstructured":"N. Mauras, D. Shulman, H.Y. Hsiang, P. Balagopal, S. Welch, Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome. J. Clin. Endocrinol. Metab. 92, 4154\u20134160 (2007). doi: 10.1210\/jc.2007-0671","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9569_CR186","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/080352501750197665","volume":"90","author":"RW Naeraa","year":"2001","unstructured":"R.W. Naeraa, C.H. Gravholt, K.W. Kastrup, B. Svenstrup, J.S. Christiansen, Morning versus evening administration of estradiol to girls with turner syndrome receiving growth hormone: impact on growth hormone and metabolism. A randomized placebo-controlled crossover study. Acta Paediatr. 90, 526\u2013531 (2001)","journal-title":"Acta Paediatr."},{"key":"9569_CR187","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(08)70033-0","volume":"9","author":"MJ Schoemaker","year":"2008","unstructured":"M.J. Schoemaker, A.J. Swerdlow, C.D. Higgins, A.F. Wright, P.A. Jacobs, Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. Lancet Oncol. 9, 239\u2013246 (2008). doi: 10.1016\/S1470-2045(08)70033-0","journal-title":"Lancet Oncol."},{"key":"9569_CR188","doi-asserted-by":"crossref","first-page":"E1517","DOI":"10.1210\/jc.2011-0346","volume":"96","author":"K Freriks","year":"2011","unstructured":"K. Freriks, J. Timmermans, C.C. Beerendonk, C.M. Verhaak, R.T. Netea-Maier, B.J. Otten, D.D. Braat, D.F. Smeets, D.H. Kunst, A.R. Hermus, H.J. Timmers, Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with turner syndrome. J. Clin. Endocrinol. Metab. 96, E1517\u2013E1526 (2011). doi: 10.1210\/jc.2011-0346","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9569-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-011-9569-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9569-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:17:34Z","timestamp":1713179854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-011-9569-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":188,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["9569"],"URL":"https:\/\/doi.org\/10.1007\/s12020-011-9569-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}